Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamic

4.1 Growth Drivers
4.2 Challenges
4.3 Opportunities


5. Global Human Microbiome Market


6. Global Human Microbiome Market Share Analysis

6.1 By Application
6.2 By Disease
6.3 By Product
6.4 By Geography


7. Application

7.1 Therapeutics
7.2 Diagnostics


8. Disease

8.1 Obesity
8.2 Diabetes
8.3 Autoimmune Disorders
8.4 Cancer
8.5 Gastrointestinal Disorders
8.6 Central Nervous System Disorders
8.7 Other Diseases


9. Product

9.1 Probiotics
9.2 Prebiotics
9.3 Symboitics
9.4 Other Products


10. Geography

10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey

10.3 Asia Pacific

10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 Australia
10.3.5 South Korea
10.3.6 Thailand
10.3.7 Malaysia
10.3.8 Indonesia
10.3.9 New Zealand

10.4 Latin America

10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina

10.5 Middle East & Africa

10.5.1 South Africa
10.5.2 Saudi Arabia
10.5.3 United Arab Emirates


11. Porter’s Five Forces Analysis

11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Competition
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis

12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threats


13. Key Players Analysis

13.1 DuPont

13.1.1 Overviews
13.1.2 Recent Developments
13.1.3 Product Portfolio
13.1.4 Revenue

13.2 Evelo Biosciences Inc

13.2.1 Overviews
13.2.2 Recent Developments
13.2.3 Product Portfolio
13.2.4 Revenue

13.3 Finch Therapeutics Group Inc.

13.3.1 Overviews
13.3.2 Recent Developments
13.3.3 Product Portfolio
13.3.4 Revenue

13.4 Ginkgo Bioworks

13.4.1 Overviews
13.4.2 Recent Developments
13.4.3 Product Portfolio
13.4.4 Revenue

13.5 Seres Therapeutics

13.5.1 Overviews
13.5.2 Recent Developments
13.5.3 Product Portfolio
13.5.4 Revenue

13.6 AOBiome

13.6.1 Overviews
13.6.2 Recent Developments
13.6.3 Product Portfolio

13.7 Astarte Medical

13.7.1 Overviews
13.7.2 Recent Developments
13.7.3 Product Portfolio

13.8 Axial Biotherapeutics, Inc.

13.8.1 Overviews
13.8.2 Recent Developments
13.8.3 Product Portfolio

13.9 Osel Inc.

13.9.1 Overviews
13.9.2 Recent Developments
13.9.3 Product Portfolio